Abstract
Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.
Original language | English |
---|---|
Pages (from-to) | 575-582 |
Number of pages | 8 |
Journal | Nuclear Medicine Communications |
Volume | 32 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- 3-Iodobenzylguanidine
- Adrenal Gland Neoplasms
- Adult
- Aged
- Dihydroxyphenylalanine
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Paraganglioma
- Paraganglioma, Extra-Adrenal
- Pheochromocytoma
- Positron-Emission Tomography
- Recurrence
- Retrospective Studies
- Tomography, Emission-Computed, Single-Photon
- Tomography, X-Ray Computed
- Young Adult